ONCSQ (OncoSec Medical) Stock Based Compensation: $1.28 Mil (TTM As of Jan. 2023)


What is OncoSec Medical Stock Based Compensation?

OncoSec Medical ONCSQ -99.00% Stock Based Compensation is $1.28 Mil as of Jan. 2023.

OncoSec Medical's Stock Based Compensation for the three months ended in Jan. 2023 was $0.28 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jan. 2023 was $1.28 Mil.

OncoSec Medical Stock Based Compensation Related Terms

OncoSec Medical Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for OncoSec Medical's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoSec Medical Stock Based Compensation Chart

OncoSec Medical Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.25 3.50 3.52 5.14 1.65

OncoSec Medical Quarterly Data
Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.36 0.32 0.38 0.31 0.28

OncoSec Medical Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jan. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.28 Mil.

What does a Stock Based Compensation of $1.28 Mil mean?
OncoSec Medical (ONCSQ) has a Stock Based Compensation of $1.28 Mil as of Jan. 2023. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for OncoSec Medical and its competitors.
Is OncoSec Medical's Stock Based Compensation too high?
OncoSec Medical's current Stock Based Compensation is $1.28 Mil.
How does OncoSec Medical's Stock Based Compensation compare to NOVNQ and USRM?
OncoSec Medical's Stock Based Compensation of $1.28 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Biotechnology company?
A good Stock Based Compensation depends on the Biotechnology industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for OncoSec Medical and its competitors. OncoSec Medical's current Stock Based Compensation is $1.28 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoSec Medical stock overvalued right now?
OncoSec Medical (ONCSQ) has a current Stock Based Compensation of $1.28 Mil. The current Stock Based Compensation is $1.28 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For OncoSec Medical (ONCSQ), the current Stock Based Compensation is $1.28 Mil as of Jan. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoSec Medical Business Description

Address 820 Bear Tavern Road, Ewing, NJ, USA, 08628-1021
OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.